Olli-Pekka Mehtonen, MD
- 4Articles
- 22.9KReads1
- 2000–2005Active
- 33Collaborators
About
Olli-Pekka Mehtonen, MD, has published research focused on the treatment of major depressive disorder, bipolar I disorder, and schizophrenia/schizoaffective disorders. The work includes clinical trials investigating pharmacological interventions such as topiramate, lamotrigine, lithium, buspirone, venlafaxine, and sertraline. The publications span from 2000 to 2005 and involve randomized, double-blind, placebo-controlled study designs. Frequent collaborators include Kirsten Behnke, Björn G. Appelberg, Charles L. Bowden, Eila Repo-Tiihonen, and Erkka K. Syvälähti.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
